Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
Chunmin Yang, Afsar Alam, Fahad A. Alhumaydhi, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3060-3060
Open Access | Times Cited: 17

Showing 17 citing articles:

Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease
Mohammad Taufeeq, Arunabh Choudhury, Afzal Hussain, et al.
Journal of Alzheimer s Disease (2025)
Closed Access | Times Cited: 1
Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease
Saleha Anwar, Taj Mohammad, Md. Khabeer Azhar, et al.
International Journal of Biological Macromolecules (2023) Vol. 245, pp. 125364-125364
Closed Access | Times Cited: 19
In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia
Suliman A. Alsagaby, Danish Iqbal, Iqrar Ahmad, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 25
Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics
Mohd Yousuf, Anas Shamsi, Taj Mohammad, et al.
ACS Omega (2022) Vol. 7, Iss. 29, pp. 25844-25852
Open Access | Times Cited: 20
Phytochemicals Withanolide N and Dryobalanolide as Potential Bioactive Leads for Developing Anticancer Drugs Targeting Tyrosine-Protein Kinase Mer
Afzal Hussain, Taj Mohammad, Mehak Gulzar, et al.
OMICS A Journal of Integrative Biology (2025)
Closed Access
Structure-guided identification of mitogen-activated protein kinase-1 inhibitors towards anticancer therapeutics
Md Nayab Sulaimani, Sayeed Ahmed, Farah Anjum, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0311954-e0311954
Open Access
Bioactive Phytoconstituent Millettone as a Potential Inhibitor of COMT: Implications for Neuroprotective Therapy in Parkinson's Disease
Mohammad Khalid, Mohammed H. Alqarni, Ahmed I. Foudah
Journal of Pharmacology and Experimental Therapeutics (2025), pp. 103592-103592
Closed Access
Therapeutic targeting of microtubule affinity‐regulating kinase 4 in cancer and neurodegenerative diseases
Manzar Alam, Sarfraz Ahmed, Mohammad Abid, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 9, pp. 1223-1240
Open Access | Times Cited: 10
FDA-approved drugs as PIM-1 kinase inhibitors: A drug repurposed approach for cancer therapy
Aanchal Rathi, Saba Noor, Md Nayab Sulaimani, et al.
International Journal of Biological Macromolecules (2024), pp. 139107-139107
Closed Access | Times Cited: 3
Identification of natural product-based effective inhibitors of spleen tyrosine kinase (SYK) through virtual screening and molecular dynamics simulation approaches
Tufail Ali, Farah Anjum, Arunabh Choudhury, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 7, pp. 3459-3471
Closed Access | Times Cited: 5
Antioxidant and anticancer potential of ethyl acetate extract of bark and flower of Tecoma stans (Linn) and In Silico studies on phytoligands against Bcl 2 and VEGFR2 factors
Mathiyazhagan Narayanan, Anburaj Gothandapani, Rajasudha Venugopalan, et al.
Environmental Research (2023) Vol. 231, pp. 116112-116112
Closed Access | Times Cited: 4
Pharmacological inhibition of Src family kinases attenuates hyperuricemic nephropathy
Chongxiang Xiong, Jin Deng, Xin Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Identification of Potential Bioactive Phytochemicals for the Inhibition of Platelet-Derived Growth Factor Receptor β: An integrated docking and MD simulation approach
Insan Habib, Md Nayab Sulaimani, Afzal Hussain, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Toxic Features and Metabolomic Intervention of Glabrene, an Impurity Found in the Pharmaceutical Product of Glabridin
Xue Li, Haixin Jiang, Dongxue Guo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8985-8985
Open Access | Times Cited: 1
Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development
Afsha Khan, Mohamed Ahmed Bealy, Bandar Alharbi, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 4, pp. 1846-1857
Closed Access | Times Cited: 2
Structure-Based Identification of Natural Compounds as Potential RET-Kinase Inhibitors for Therapeutic Targeting of Neurodegenerative Diseases
Gulam Mustafa Hasan, Anas Shamsi, Sukhwinder Singh Sohal, et al.
Journal of Alzheimer s Disease (2023) Vol. 95, Iss. 4, pp. 1519-1533
Closed Access | Times Cited: 2
Identification of potential bioactive phytochemicals for the inhibition of platelet-derived growth factor receptor β: a structure-based approach for cancer therapy
Insan Habib, Md Nayab Sulaimani, Deeba Shamim Jairajpuri, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Assessment of AlphaFold structures and optimization methods for virtual screening
Yanfei Peng, Xia Wu, Liang Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top